The serum concentration of SFRP2 was increased in control tumor-bearing mice (8.91 ± 0.67 ng/mL), compared to non-tumor-bearing mice (3.36 ± 0.74 ng/mL, n = 3; p < 0.01; Figure 3A). Here, SFRP2 is linked to neoplasm.